Next, the patients with T1D were divided based on insulin therapy into an MDI group of 109 children (50.7%) treated with insulin pens and a CSII group of 106 children (49.3%) treated with insulin pumps. This evidence concerns the gene INS and type 1 diabetes mellitus.